Development and validation of a stability-indicating RP-HPLC method of cholecalciferol in bulk and pharmaceutical formulations: Analytical quality by design approach
Dilipkumar Suryawanshi, Durgesh Kumar Jha, Umesh Shinde, Purnima D. Amin
DOI: 10.7324/JAPS.2019.90604Pages: 021-032
Formulation of somatostatin analog tablets using quality by design approach
Zoya Shprakh
DOI: 10.7324/JAPS.2021.110412Pages: 096-105
Analytical quality by design approach for estimating rosuvastatin calcium in pharmaceutical formulation by green HPLC method: Ecologically evaluated and stability-indicating
Seetharaman Rathinam, Lakshmi Karunanidhi Santhana
DOI: 10.7324/JAPS.2021.1101119Pages: 150-160
The development of biodegradable hemostatic and absorbable sponges containing chlorhexidine digluconate and their in vitro characterization—A QbD approach
Bohdana Pavliuk, Mariana Chubka, Taras Hroshovyi, Mariana Demchuk, Iryna Stechyshyn
DOI: 10.7324/JAPS.2021.120206Pages: 056-065
QbD-based RP-HPLC method development for quantitative computation of phase III composition comprising apixaban and clopidogrel
Rashmi Shukla, Ankit Chaudhari, Pinak Patel, Krunal Detholia
DOI: 10.7324/JAPS.2024.181311Pages:
Quality by design approach for the formulation of bilayer tablets of domperidone and itopride in gastro esophageal reflux disease
Roshani Prajapati, Bhavna Kumar, Jagannath Sahoo, Shailendra Shakya, Diwya Kumar Lal
DOI: 10.7324/JAPS.2024.168489Pages:
